Not Tagged
Myricx Pharma
[]
myricx pharma presents positive pre-clinical poc data at aacr for its n-myristoyltransferase inhibitor (nmti) adc programme alongside new biology on novel moa for nmti 
We provide a balanced view on small cap biotech equities.